AssetMark’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
AssetMark's HAE Position: Q3 2026 in Review
AssetMark held its Haemonetics (HAE) position steady in Q3 2026 at 8 shares worth $842. The position accounts for ﹤0.01% of the portfolio, ranked #3277.
AssetMark first reported a position in HAE in Q4 2017 and has held it in 23 quarters since. The position peaked at $42K in Q4 2020. 269 funds tracked by Wall St. Rank hold HAE as of Q3 2026.
- AssetMark held 8 shares of Haemonetics worth $842 as of Q3 2026.
- AssetMark left its Haemonetics share count unchanged in Q3 2026.
- Haemonetics made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #3277 holding.
- AssetMark first reported a position in Haemonetics in Q4 2017 and has held it in 23 quarters since.
- AssetMark's Haemonetics position peaked at $42K in Q4 2020.
- 269 funds tracked by Wall St. Rank held Haemonetics as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.